Akebia Therapeutics, Inc.

By person

30 insiders · 142 transactions

5.4×

John P. Butler holds 5.4 times base salary in stock. $4.68M of shares against $864.01K in salary for 2025.

Salary from the company's own proxy. The shares are what John P. Butler last reported holding, valued at $1.11, the price Common Stock was last bought or sold at on the open market here, on 29 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Satter Muneer A

Director

$15.00M (1)

—

+$15.00M

3,037,042

1.10%

$3.37M

+51.7%

Butler John P.

CEO and President

$258.59K (2)

$1.54M (21) scheduled

−$1.28M

4,217,314

1.52%

$4.68M

+567.4%

Dahan Michel

SVP, Chief Operating Officer

—

$639.00K (23)

−$639.00K

672,092

0.2425%

$746.02K

+670.3%

Hadas Nicole R.

SVP, Chief Legal Officer

—

$513.60K (22)

−$513.60K

651,243

0.2350%

$722.88K

+520.9%

Burke Steven Keith

SVP, Chief Medical Officer

$96.66K (1)

$460.80K (22)

−$364.14K

948,432

0.3423%

$1.05M

+6,223%

Ostrowski Erik

SVP, CFO, CBO & Treasurer

—

$262.39K (3) scheduled

−$262.39K

616,616

0.2225%

$684.44K

—

Malabre Richard C

SVP, Chief Accounting Officer

—

$239.48K (5) scheduled

−$239.48K

299,390

0.1080%

$332.32K

+6,553%

Grund Nicholas

Chief Commercial Officer

—

$234.72K (3) scheduled

−$234.72K

561,750

0.2027%

$623.54K

—

ADAMS ADRIAN

Director

$170.50K (1)

—

+$170.50K

236,200

0.0852%

$262.18K

—

Faulkingham Dell

SVP, CCO

—

$129.09K (6)

−$129.09K

173,841

0.0627%

$192.96K

—

Spellman David A

SVP, CFO and Treasurer

—

$100.72K (7)

−$100.72K

446,483

0.1611%

$495.60K

—

Nash Duane

Director

—

$99.66K (6)

−$99.66K

21,499

0.0078%

$23.86K

−27.4%

Rucci Carolyn M.

SVP, Chief Legal Officer

—

$96.98K (3) scheduled

−$96.98K

588,378

0.2123%

$653.10K

+25.7%

Amello Jason

SVP, CFO & Treasurer

—

$60.69K (1)

−$60.69K

144,642

0.0522%

$160.55K

+240.3%

GOWEN MAXINE

Director

—

$55.03K (1)

−$55.03K

24,133

0.0087%

$26.79K

+1,756%

GILMAN STEVEN C

Director

$19.89K (1)

$71.99K (3)

−$52.09K

152,830

0.0552%

$169.64K

—

Tubridy Karen L

SVP, Chief Development Officer

—

$30.05K (1)

−$30.05K

84,679

0.0306%

$93.99K

+1,402%

Cotreau Violetta

SVP, Chief Accounting Officer

—

$21.84K (2)

−$21.84K

219,954

0.0794%

$244.15K

+1,605%

Smith Cynthia

Director

$52.80K (1)

$55.26K (1)

−$2.46K

196,633

0.0710%

$218.26K

—

Snow Ellen

SVP, CFO and Treasurer

—

519,300

0.1874%

$576.42K

—

ROGERS MICHAEL W

Director

—

197,429

0.0712%

$219.15K

—

Wolf Myles

Director

—

169,081

0.0610%

$187.68K

+1,545%

FRIESON RON

Director

—

165,200

0.0596%

$183.37K

—

ZUMWALT LEANNE M

Director

—

145,100

0.0524%

$161.06K

—

Jain Rita

SVP, Chief Medical Officer

—

96,332

0.0348%

$106.93K

—

Maroni Bradley

SVP and Chief Medical Officer

—

64,585

0.0233%

$71.69K

+57.2%

Morrison Jodie Pope

Director

—

58,619

0.0212%

$65.07K

—

Heffernan Michael Thomas

Director

—

48,586

0.0175%

$53.93K

—

Enyedy Mark J

Director

—

31,143

0.0112%

$34.57K

—

Canute Scott A

Director

—

13,700

0.0049%

$15.21K

—

Akebia Therapeutics, Inc.

By person

Individual transactions

What was left out